Researchers sought to determine whether changes in physical function during intensive chemotherapy would affect post-transplant survival in older adults with AML.
Researchers sought to determine whether reducing IV crystalloid fluid administration may decrease the risk of respiratory failure in patients receiving haplo-SCT.
Researchers sought to determine whether siltuximab would be safe and effective for treating CRS and ICANS associated with CAR-T therapy.
Researchers evaluated whether patients who undergo allo-HCT who have a rapid and robust immune recovery have improved clinical outcomes, including OS rates.
Researchers sought to determine whether adding RGI-2001 to a calcineurin inhibitor and methotrexate or mycophenolate mofetil would help prevent acute GVHD.
Pano/GBM is safe and effective as conditioning before ASCT in patients with high-risk or relapsed/refractory multiple myeloma, a study suggests.
Zamtocabtagene autoleucel produced responses in patients with relapsed/refractory diffuse large B-cell lymphoma in a phase 2 trial.
Please login or register first to view this content.
